NO177793C - Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten

Info

Publication number: NO177793C
Authority: NO; Norway
Prior art keywords: preparation; nucleic acid; well; host cell; fusion protein
Prior art date: 1986-11-01

Application number

NO882917A

Other languages

English (en)

Other versions

NO882917D0 (no

NO882917L (no

NO177793B (no

Inventor

Alan John Kingsman

Susan Mary Kingsman

Sally Elizabeth Adams

Michael Henry Malim

Elizabeth-Jane Claire Mellor

Original Assignee

British Bio Technology

Oxford Gene Systems Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-01

Filing date

1988-06-30

Publication date

1995-11-22

1986-11-01 Priority claimed from GB868626148A external-priority patent/GB8626148D0/en

1987-04-09 Priority claimed from GB878708531A external-priority patent/GB8708531D0/en

1987-04-10 Priority claimed from US07/036,807 external-priority patent/US5041385A/en

1988-06-30 Application filed by British Bio Technology, Oxford Gene Systems Ltd filed Critical British Bio Technology

1988-06-30 Publication of NO882917D0 publication Critical patent/NO882917D0/no

1988-08-29 Publication of NO882917L publication Critical patent/NO882917L/no

1995-08-14 Publication of NO177793B publication Critical patent/NO177793B/no

1995-11-22 Publication of NO177793C publication Critical patent/NO177793C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)

NO882917A 1986-11-01 1988-06-30 Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten NO177793C (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB868626148A GB8626148D0 (en)	1986-11-01	1986-11-01	Antigen presentation & purification system
GB878708531A GB8708531D0 (en)	1987-04-09	1987-04-09	Fusion proteins & particles
US07/036,807 US5041385A (en)	1986-11-01	1987-04-10	Vector expressing fusion proteins and particles
PCT/GB1987/000764 WO1988003563A1 (en)	1986-11-01	1987-10-28	Fusion proteins and particles

Publications (4)

Publication Number	Publication Date
NO882917D0 NO882917D0 (no)	1988-06-30
NO882917L NO882917L (no)	1988-08-29
NO177793B NO177793B (no)	1995-08-14
NO177793C true NO177793C (no)	1995-11-22

Family

ID=27263194

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882917A NO177793C (no)	1986-11-01	1988-06-30	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten

Country Status (8)

Country	Link
EP (1)	EP0330661B1 (no)
JP (2)	JP2708046B2 (no)
AU (1)	AU606896B2 (no)
CA (1)	CA1339263C (no)
DE (1)	DE3788807T2 (no)
ES (1)	ES2010231A6 (no)
NO (1)	NO177793C (no)
WO (1)	WO1988003563A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003562A1 (en) *	1986-11-01	1988-05-19	Oxford Gene Systems Limited	Particulate hybrid hiv antigens
US5614404A (en) *	1988-06-10	1997-03-25	Theriod Biologics, Incorporated	Self-assembled, defective, non-self-propagating lentivirus particles
US5631154A (en) *	1988-06-10	1997-05-20	Therion Biologics, Incorporated	Self assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) *	1988-06-10	1998-05-05	Therion Biologics Corporation	Self-assembled, defective, non-self-propagating lentivirus particles
JPH04504950A (ja) *	1988-11-23	1992-09-03	ザリージェンツオブザユニバーシティオブカリフォルニア	位置特異的挿入ベクターおよびこれを用いた方法
JPH04500308A (ja) *	1989-05-17	1992-01-23	リサーチ・コーポレーション・テクノロジーズ・インコーポレーテッド	組換え型生成物のレトロウィルス媒介分泌
EP0474868B1 (en) *	1989-05-30	1996-11-13	Nippon Zeon Co., Ltd.	Method of producing core structure of retro virus and particle produced thereby
EP0431128B1 (en) *	1989-06-01	2003-03-26	Applied Biotechnology, Inc.	Vector coding for self-assembled, defective, non-self-propagating viral particles
WO1991019803A1 (en) *	1990-06-19	1991-12-26	Applied Biotechnology, Incorporated	Self assembled, defective, nonself-propagating viral particles
GB9107631D0 (en) *	1991-04-10	1991-05-29	British Bio Technology	Proteinaceous particles
GB9223084D0 (en) *	1992-11-04	1992-12-16	Imp Cancer Res Tech	Compounds to target cells
FR2703996B1 (fr)	1993-04-16	1995-07-21	Transgene Sa	Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote.
ATE362990T1 (de) *	1999-06-30	2007-06-15	Evotec Ag	Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung
US20040014033A1 (en)	1999-06-30	2004-01-22	Evotec Biosystems Ag, A Corporation Of Germany	Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US7476517B2 (en)	1999-06-30	2009-01-13	Evotec Ag	Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
EP1219705B1 (en) *	2000-12-29	2007-11-28	Evotec AG	Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
FI116198B (fi)	2001-07-16	2005-10-14	Valtion Teknillinen	Polypeptidien immobilisointimenetelmä
LT5414B (lt)	2005-04-13	2007-04-25	Biotechnologijos Institutas	Monokloninių antikūnų gavimo būdas, hibridomos, gautos šiuo būdu ir rekombinantinės chimerinės į virusus panašios dalelės su įterptais kitų baltymų fragmentais kaip imunogenai hibridomų gavimui šiuo būdu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8324800D0 (en) *	1983-09-15	1983-10-19	Pasteur Institut	Antigens
JPS6193199A (ja) *	1984-10-13	1986-05-12	Kyowa Hakko Kogyo Co Ltd	抗インタ−フエロン−γモノクロ−ナル抗体

1987
- 1987-10-28 DE DE3788807T patent/DE3788807T2/de not_active Expired - Fee Related
- 1987-10-28 EP EP87906926A patent/EP0330661B1/en not_active Expired - Lifetime
- 1987-10-28 JP JP62506664A patent/JP2708046B2/ja not_active Expired - Fee Related
- 1987-10-28 WO PCT/GB1987/000764 patent/WO1988003563A1/en active IP Right Grant
- 1987-10-28 AU AU81057/87A patent/AU606896B2/en not_active Ceased
- 1987-10-30 ES ES878703105A patent/ES2010231A6/es not_active Expired
- 1987-10-30 CA CA000550668A patent/CA1339263C/en not_active Expired - Fee Related
1988
- 1988-06-30 NO NO882917A patent/NO177793C/no not_active IP Right Cessation
1996
- 1996-05-23 JP JP8128724A patent/JPH09248191A/ja active Pending

Also Published As

Publication number	Publication date
JP2708046B2 (ja)	1998-02-04
NO882917D0 (no)	1988-06-30
CA1339263C (en)	1997-08-12
AU606896B2 (en)	1991-02-21
JPH09248191A (ja)	1997-09-22
JPH02501026A (ja)	1990-04-12
NO882917L (no)	1988-08-29
EP0330661B1 (en)	1994-01-12
WO1988003563A1 (en)	1988-05-19
DE3788807T2 (de)	1994-06-30
NO177793B (no)	1995-08-14
DE3788807D1 (de)	1994-02-24
EP0330661A1 (en)	1989-09-06
AU8105787A (en)	1988-06-01
ES2010231A6 (es)	1989-11-01

Similar Documents

Publication	Publication Date	Title
NO177793C (no)	1995-11-22	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten
NO177794C (no)	1995-11-22	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten
NO175715C (no)	1994-11-23	Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater, samt mellomprodukter ved fremstilling av disse
DK247084D0 (da)	1984-05-17	7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer,fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
DK110885A (da)	1985-09-13	Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
NO871785D0 (no)	1987-04-29	Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
IT7921838A0 (it)	1979-04-13	Processo di rivelazione e di caratterizzazione di un acido nucleico o di una sua sequenza e reattivo enzimatico per la realizzazione di questo processo.
DK374087A (da)	1988-01-19	Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
NO964445D0 (no)	1996-10-18	DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA
NZ221790A (en)	1990-07-26	Method for the continuous production of a heterologous protein in a eukaryotic host cell
DE69127829D1 (de)	1997-11-06	Expression von pace in wirtszellen und verfahren zu dessen verwendung
AU587989B2 (en)	1989-09-07	DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
NO179109C (no)	1996-08-07	Ekspresjonsvektor, rekombinante vertsceller samt fremgangsmåte for fremstilling av terapeutisk aktivt, rekombinant CSF
DK388789A (da)	1990-02-10	Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
IT8520036A0 (it)	1985-03-22	Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi.
DK534286A (da)	1987-05-10	Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling
DK124787A (da)	1987-09-13	Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen
NO174167C (no)	1994-03-23	Fremgangsmåte til fremstilling av mekanisk masse, samt anvendelse av enzymer og/eller kjemikalier ved fremstilling av mekanisk masse
DK354188D0 (da)	1988-06-27	Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
WO1994025590A3 (en)	1994-12-22	Trichohyalin and transglutaminase-3 and methods of using same
JPS5550892A (en)	1980-04-14	Protein production * modified dna and vector applicable to said method
DK94385D0 (da)	1985-02-28	Proteiner, farmaceutiske praeparater, gener, vektorer, vaertsorganismer samt fremgangsmaader til deres fremstilling
BR9106555A (pt)	1993-06-22	Proteina,celula hospedeira e processos para a preparacao de uma proteina e de acido nucleico
PT90768A (pt)	1989-12-29	Processo para a preparacao de vectores de expressao e de proteinas nao fundidas usando esses vectores em microorganismos
AU6521186A (en)	1987-05-19	Lytic viruses as expression vectors, host cell containing same and process for protein production

Legal Events

Date	Code	Title	Description
2003-06-02	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN APRIL 2003